13 Inflammatory Bowel Disease Clinical Trials in Kissimmee, FL (2026)

Q: How do I join a clinical trial in Kissimmee?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Kissimmee research site will contact you.

Recruiting Inflammatory Bowel Disease Studies in Kissimmee

NCT07185009Recruiting

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

This is a multicenter, randomized, double-blind, placebo-controlled Phase 3 maintenance study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcera...

Kissimmee, FLPHASE3751 participantsSanofi

View Study Details

NCT07184944Recruiting

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

This is a multicenter, randomized, double-blind, placebo-controlled, maintenance, Phase 3 study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Croh...

Kissimmee, FLPHASE3751 participantsSanofi

View Study Details

NCT07012395Recruiting

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary goal of the study is to assess the efficac...

Kissimmee, FLPHASE2645 participantsSpyre Therapeutics, Inc.

View Study Details

NCT06226883Recruiting

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of 2 active dose regimens of MORF-057 in adult study participants with moderately...

Kissimmee, FLPHASE2385 participantsMorphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)

View Study Details

NCT06619990Recruiting

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Brief summary The Phase 1 study described herein will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of XmAb942 in healthy volunteers (Parts A and B). Part C of this study wi...

Kissimmee, FLPHASE1270 participantsXencor, Inc.

View Study Details

NCT07186101Recruiting

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

The main purpose of the study is to evaluate the effectiveness and safety of LY4268989 when given with mirikizumab compared to mirikizumab alone in adult participants with moderately to severely activ...

Kissimmee, FLPHASE2252 participantsEli Lilly and Company

View Study Details

NCT05442567Recruiting

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

The study is an extension of two parent studies (MLN0002-3024 \[NCT04779307\] and MLN0002-3025 \[NCT04779320\]). Participants must have participated in one of the previous studies. The purpose of this...

Kissimmee, FLPHASE3240 participantsTakeda

View Study Details

NCT06979336Recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

The purpose of this study is to evaluate the efficacy of RO7837195 compared with placebo in participants with moderately to severely active ulcerative colitis for whom prior treatment with conventiona...

Kissimmee, FLPHASE2224 participantsGenentech, Inc.

View Study Details

NCT04779320Recruiting

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Vedolizumab is a medicine that helps to reduce inflammation and pain in the digestive system. In this study, children and teenagers with moderate to severe Crohn's disease will be treated with vedoliz...

Kissimmee, FLPHASE3120 participantsTakeda

View Study Details

NCT06958536Recruiting

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

This is a phase 2b, randomized, double-blind, 3-arm study for the treatment of Crohn's disease. The primary objective of this study is to assess the efficacy of different doses of SAR442970 compared w...

Kissimmee, FLPHASE299 participantsSanofi

View Study Details

NCT06636656Recruiting

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

Adults between 18 and 80 years of age with ulcerative colitis can participate in this study. This is a study for people for whom previous treatment was not successful or who stopped previous treatment...

Kissimmee, FLPHASE280 participantsBoehringer Ingelheim

View Study Details

NCT06045754Recruiting

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with adalimumab or vedolizumab (VDZ) together with ustekinumab (UST) in adults with mode...

Kissimmee, FLPHASE450 participantsTakeda

View Study Details

NCT07368972Recruiting

Study of DISC-0974-201 in Participants With IBD and Anemia

This is a Phase 2, multicenter, randomized, double-blind placebo-controlled study of DISC-0974 to evaluate safety, tolerability, and efficacy in participants with IBD and anemia of inflammation....

Kissimmee, FLPHASE221 participantsDisc Medicine, Inc

View Study Details

About Inflammatory Bowel Disease Clinical Trials in Kissimmee

Inflammatory bowel disease (IBD) encompasses chronic inflammatory conditions of the gastrointestinal tract, primarily Crohn's disease and ulcerative colitis. It affects millions worldwide and can cause debilitating symptoms. Treatment includes anti-inflammatory drugs, immunosuppressants, biologics, and surgery.

There are currently 13 inflammatory bowel disease clinical trials recruiting participants in Kissimmee, FL. These studies are seeking a combined 3,888 participants. Research is being sponsored by Sanofi, Spyre Therapeutics, Inc., Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Inflammatory Bowel Disease Clinical Trials in Kissimmee — FAQ

Are there inflammatory bowel disease clinical trials in Kissimmee?

Yes, there are 13 inflammatory bowel disease clinical trials currently recruiting in Kissimmee, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Kissimmee?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Kissimmee research site will contact you about next steps.

Are clinical trials in Kissimmee free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Kissimmee studies also compensate for your time and travel.

What inflammatory bowel disease treatments are being tested?

The 13 active trials in Kissimmee are testing new therapies including novel drugs, biologics, and treatment approaches for inflammatory bowel disease.

Data updated October 17, 2026 from ClinicalTrials.gov